The Efficacy of Rituximab in High-risk Renal Transplant Recipients.

Araki, Motoo; Wada, Koichiro; Mitsui, Yosuke; Kubota, Risa; Yoshioka, Takashi; Ariyoshi, Yuichi; Kobayashi, Yasuyuki; Kitagawa, Masashi; Tanabe, Katsuyuki; Sugiyama, Hiroshi; Wada, Jun; Watanabe, Masami; Watanabe, Toyohiko; Hotta, Katsuyuki; Nasu, Yasutomo

Araki, Motoo; Wada, Koichiro; Mitsui, Yosuke; Kubota, Risa; Yoshioka, Takashi; Ariyoshi, Yuichi; Kobayashi, Yasuyuki; Kitagawa, Masashi; Tanabe, Katsuyuki; Sugiyama, Hiroshi; Wada, Jun; Watanabe, Masami; Watanabe, Toyohiko; Hotta, Katsuyuki; Nasu, Yasutomo.

Affiliation

Araki M; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.motoosh@md.okayama-u.ac.jp.

Acta Med Okayama ; 70(4): 295-7, 2016 Aug.

Article in En | MEDLINE | ID: mdl-27549676

Subject(s)

Graft Rejection/prevention & control; Kidney Transplantation; Rituximab/therapeutic use; ABO Blood-Group System; Asian People; Blood Group Incompatibility; Clinical Protocols; Humans; Research Design

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Kidney Transplantation / Rituximab / Graft Rejection Type of study: Etiology_studies / Guideline / Risk_factors_studies Limits: Humans Language: En Journal: Acta Med Okayama Year: 2016 Type: Article

Search on Google

XML

PubMed Links